Inhalable Biological Drug For Treating Bronchiectasis, Other Severe Pulmonary Diseases Enters Clinical Trials
News
Building on Novozymes Biopharma’s recombinant human albumin Recombumin, Denmark-based Serendex Pharmaceuticals’ leading drug candidate Molgradex — a Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) — has entered Phase I clinical trials. ... Read more